Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Affiliation:
      Clinical Nurse, Cancer Centre, St John of God Murdoch Hospital, Murdoch, WA 6150, Australia
      Nurse Researcher, Centre for Nursing and Midwifery Research, St John of God Murdoch Hospital, Murdoch, WA 6150, Australia
      Adjunct Senior Lecturer, School of Nursing and Midwifery, University of Notre Dame Australia, Fremantle, WA 6959, Australia
      Chair of Nursing, Centre for Nursing and Midwifery Research, St John of God Murdoch Hospital, Murdoch, WA, 6150, Australia
      School of Nursing and Midwifery, University of Notre Dame Australia, Fremantle, WA 6959, Australia
      Adjunct Professor of Nursing, School of Nursing and Midwifery, Edith Cowan University, Joondalup, WA 6027, Australia
      Adjunct Professor, Ngangk Yira Research Centre for Aboriginal Health and Social Equity, Murdoch University, Murdoch, WA 6150, Australia
      Adjunct Professor, College of Science, Health, Engineering and Education, Murdoch University, Murdoch, WA 6150, Australia
    • Subject Terms:
    • Subject Terms:
    • Abstract:
      Introduction Clinical practice guidelines based on best available evidence and national safety and quality standards promote high quality and safe care. Aim To review and standardise systemic anti-cancer therapy (SACT) forms in a 20-chair cancer centre to reflect Australian and international clinical practice guidelines. Method A pre--post audit design based on Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of systemic cancer therapy underpinned the project. The pre-audit (47 forms) provided a benchmark for SACT form improvements: 177 new forms were then developed over 18 months and implemented. Results Pre-audit: 9/19 criteria were >70% compliant with best practice guidelines. Post-SACT implementation audit: 15/19 criteria were >70% compliant. The recent 2018 audit: improvements shown in 18/19 criteria. Conclusion This nurse-led multidisciplinary initiative effectively standardised SACT charts with best practice guidelines, potentially reducing serious medication errors and facilitating a high standard of multidisciplinary patient care.
    • Journal Subset:
      Australia & New Zealand; Double Blind Peer Reviewed; Editorial Board Reviewed; Nursing; Peer Reviewed
    • ISSN:
      1441-2551
    • Publication Date:
      20200720
    • Publication Date:
      20200723
    • DOI:
      10.33235/ajcn.21.1.4-8
    • Accession Number:
      144343551
  • Citations
    • ABNT:
      SIM, F.; ROSS-ADJIE, G.; MONTEROSSO, L. Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation. Australian Journal of Cancer Nursing, [s. l.], v. 21, n. 1, p. 4–8, 2020. DOI 10.33235/ajcn.21.1.4-8. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=rzh&AN=144343551. Acesso em: 30 set. 2020.
    • AMA:
      Sim F, Ross-Adjie G, Monterosso L. Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation. Australian Journal of Cancer Nursing. 2020;21(1):4-8. doi:10.33235/ajcn.21.1.4-8
    • APA:
      Sim, F., Ross-Adjie, G., & Monterosso, L. (2020). Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation. Australian Journal of Cancer Nursing, 21(1), 4–8. https://doi.org/10.33235/ajcn.21.1.4-8
    • Chicago/Turabian: Author-Date:
      Sim, Felicity, Gail Ross-Adjie, and Leanne Monterosso. 2020. “Standardisation of Systemic Anti-Cancer Therapy (SACT) Prescription Forms: A Pre--Post Audit Evaluation.” Australian Journal of Cancer Nursing 21 (1): 4–8. doi:10.33235/ajcn.21.1.4-8.
    • Harvard:
      Sim, F., Ross-Adjie, G. and Monterosso, L. (2020) ‘Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation’, Australian Journal of Cancer Nursing, 21(1), pp. 4–8. doi: 10.33235/ajcn.21.1.4-8.
    • Harvard: Australian:
      Sim, F, Ross-Adjie, G & Monterosso, L 2020, ‘Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation’, Australian Journal of Cancer Nursing, vol. 21, no. 1, pp. 4–8, viewed 30 September 2020, .
    • MLA:
      Sim, Felicity, et al. “Standardisation of Systemic Anti-Cancer Therapy (SACT) Prescription Forms: A Pre--Post Audit Evaluation.” Australian Journal of Cancer Nursing, vol. 21, no. 1, June 2020, pp. 4–8. EBSCOhost, doi:10.33235/ajcn.21.1.4-8.
    • Chicago/Turabian: Humanities:
      Sim, Felicity, Gail Ross-Adjie, and Leanne Monterosso. “Standardisation of Systemic Anti-Cancer Therapy (SACT) Prescription Forms: A Pre--Post Audit Evaluation.” Australian Journal of Cancer Nursing 21, no. 1 (June 2020): 4–8. doi:10.33235/ajcn.21.1.4-8.
    • Vancouver/ICMJE:
      Sim F, Ross-Adjie G, Monterosso L. Standardisation of systemic anti-cancer therapy (SACT) prescription forms: a pre--post audit evaluation. Australian Journal of Cancer Nursing [Internet]. 2020 Jun [cited 2020 Sep 30];21(1):4–8. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=rzh&AN=144343551